Question 1

Has Agne Paner received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $214,988 in general payments to Agne Paner across 74 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Agne Paner did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Agne Paner come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	9	$53,795
GSK	15	$52,850
Bristol Myers Squibb	8	$50,637
Amgen	13	$21,927
Johnson & Johnson	13	$19,569
Adaptive Biotechnologies Corporation	5	$4,085
Janssen Research & Development, LLC	1	$3,720
AbbVie	2	$2,735
Pfizer	2	$2,160
Sanofi	2	$2,043
Dova Pharmaceuticals	2	$1,400
Janssen Scientific Affairs, LLC	2	$67

Agne Paner

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other hematology & oncology in Maywood